Expression of constitutive cyclooxygenase (COX-1) in rats with streptozotocin-induced diabetes; effects of treatment with evening primrose oil or an aldose reductase inhibitor on COX-1 mRNA levels

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 56, Issue 2, 1997, Pages 157-163

  Fang, C ^a   Jiang, Z ^a   Tomlinson, D R ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; CYCLOOXYGENASE 1; MESSENGER RNA; MINALRESTAT; PRIMROSE OIL; ALDEHYDE REDUCTASE; CYCLOOXYGENASE 2; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; ISOENZYME; LINOLEIC ACID; MEMBRANE PROTEIN; PRIMER DNA; PROSTAGLANDIN SYNTHASE; PTGS1 PROTEIN, RAT; VEGETABLE OIL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HISTOCHEMISTRY; KIDNEY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETINA; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; STREPTOZOCIN DIABETES; THORACIC AORTA; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; POLYMERASE CHAIN REACTION; RAT; WISTAR RAT;

ANIMALIA; OENOTHERA; PRIMULA;

ALDEHYDE REDUCTASE; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BODY WEIGHT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIABETES MELLITUS, EXPERIMENTAL; DNA PRIMERS; FATTY ACIDS, ESSENTIAL; GAMMA-LINOLENIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; LINOLEIC ACIDS; MALE; MEMBRANE PROTEINS; PLANT OILS; POLYMERASE CHAIN REACTION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; RNA, MESSENGER; SCIATIC NERVE;

EID: 0030614957     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90513-5     Document Type: Article

References (47)

1. McManis P. G., Low P. A., Lagerlund D. Microenvironrnent of nerve: blood flow and ischemia. In: Dyck P. J., Thomas P. K., eds. Peripheral Neuropathy. Philadelphia: W. B. Saunders Company. 1993: 453-473.
2. DeRubertis F. R., Craven P. A. Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. Am J Kidney Dis 1993; 22: 727-735.
3. Horrobin D. F. Essential fatty acids and the complications of diabetes mellitus. Wien Klin Wochenschr 1989; 101: 289-293.
4. Ward K. K., Low P. A., Schmelzer J. D., Zochodne D. W. Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 1989; 112: 197-208.
5. Cohen R. A. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993; 87 Suppl. 5: V67-V76.
6. Roth D. M., Reibel D. K., Lefer A. M. Vascular responsiveness and eicosanoid production in diabetic rats. Diabetologia 1983; 242: 372-376.
7. Maier J. A., Hla T., Maciag T. Cyclooxygenase is an immediateearly gene induced by interleukin-1 in human endothelial cells. J Biol Chem 1990; 265: 10805-10808.
8. Feng L., Sun W., Xia Y., et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 1993; 307: 361-368.
9. Siebert P. D., Larrick J. W. Competitive PCR. Nature 1992; 359: 557-558.
10. Holman R. T., Johnson S. B., Gerrard J. M., Michael Mauer S., Kupcho-Sandberg S., Brown D. M. Arachidonic acid deficiency in streptozotocin-induced diabetes. Proc Natl Acad Sci USA 1983; 80: 2375-2379.
11. Ramsammy L. S., Haynes B., Josepovitz C., Kaloyanides G.J. Mechanism of decreased arachidonic acid in the renal cortex of rats with diabetes mellitus. Lipids 1993; 28: 433-439.
12. Dines K. C., Cotter M. A., Cameron N. E. Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia 1993; 36: 1132-1138.
13. Tomlinson D. R., Robinson J. P., Compton A. M., Keen P. Essential fatty acid treatment-effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats. Diabetologia 1989; 32: 655-659.
14. Stevens E. J., Carrington A. L., Tomlinson D. R. Prostacyclin release in experimental diabetes: effects of evening primrose oil. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 699-706.
15. Cameron N. E., Cotter M. A., Dines K. C., Robertson S., Cox D. The effects of evening primrose oil on nerve function and capillarization in streptozotoein-diabetic rats: Modulation by the cyclo-oxygenase inhibitor flurbiprofen. Br J Pharmacol 1993; 109: 972-979.
16. Chang W. P., Dimitriadis E., Allen T., Dunlop M. E., Cooper M., Larkins R. G. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia 1991; 34: 225-231.
17. Wakasugi M., Noguchi T., Inoue M., Tawata M., Shindo H., Onaya T. Effeets of aldose reductase inhibitors on prostacyclin (PGI2) synthesis by aortic rings from rats with streptozotocin-induced diabetes. Prostaglandins Leukot Essent Fatty Acids 1991; 44: 233-236.
18. Stevens E. J., Willars G. B., Iidbury P., House F., Tomlinson D. R. Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: effects of insulin or aldose reductase inhibition. Br J Pharmacol 1993; 109: 980-986.
19. Tesfamariam B., Palacino J. J., Weisbrod R. M., Cohen R. A. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol 1993; 21: 205-211.
20. Calcutt N. A., Li L., Yaksh T. L., Malmberg A. B. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur J Pharmacol 1995; 285: 189-197.
21. Lin A. H., Bienkowski M.J., Gorman R. R. Regulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by platelet-derived growth factor. J Biol Chem 1989; 264: 17379-17383.
22. Diaz A., Reginato A. M., Jimenez S. A. Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1, interleukin 1 beta, and tumor necrosis factor alpha. J Biol Chem 1992; 267: 10816-10822.
23. Jackson B. A., Goldstein R. H., Roy R., Cozzani M., Taylor L., Polgar P. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 1993; 197: 1465-1474.
24. Rzymkiewicz D., Leingang K, Baird N., Morrison A. R. Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-Iß. Am J Physiol 1994; 266: 39-45.
25. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
26. Smith W. L. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 1992; 263: 181-191.
27. Karpen C. W., Pritchard K. A. J., Arnold H., Cornwell D. G., Pangamala R. V. Restoration of prostacyclin/thromboxane A2 balance in the diabetic rat: influence of dietary vitamin E. Diabetes 1982; 31: 947-951.
28. Ishii D. N., Guertin D. M., Whalen L. R. Reduced insulin-like growth factor-I mRNA content in liver., adrenal glands and spinal cord of diabetic rats. Diabetologia 1994; 37: 1073-1081.
29. Friedman N., Gellhorn A., Benjamin W. Sythesis of arachidonic acid from linoleic acid in vivo in diabetic rats. Israel J Med Sci 1966; 2: 677-681.
30. 14 gamma-linolenic and dihomogammalinolenic acids into arachidonic acid in kidneys and whole rat. Diabetic Med 1985; 11: 289-294.
31. Oshima T., Yoshimoto T., Yamamoto S., Kumegawa M., Yokoyama C., Tanabe T. cAMP-dependent induction of fatty acid cyclooxygenase mRNA in mouse osteoblastic cells (MC3T3-E1). J Biol Chem 1991; 266: 13621-13626.
32. Scholey J. W., Mills D. E. Dietary fatty acids and the glomerular hemodynamic response to cyclosporine in borderline hypertensive rats. Kidney Int 1995; 47: 611-617.
33. Milner L. S., Wei S., Kazakoff P., Watkins L., Houser M. T. Synergistic effects of fish oil diet and dimethylthiourea in acute adriamycin nephrosis. Am J Med Sci 1994; 308: 266-270.
34. Papanikolaou N. Alteration of mercuric chloride-induced autoimmune glomerulonephritis in brown-Norway rats by herring oil, evening primrose oil and OKY-046 a selective TXA-synthetase inhibitor. Prostaglandins Leukot Med 1987; 27: 129-149.
35. Hla T., Maciag T. Cyclooxygenase gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells. J Biol Chem 1991; 266: 24059-24063.
36. Tang S., Le Ruppert K. C. Activated T lymphocytes in epiretinal membranes from eyes of patients with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1995; 233: 21-25.
37. Patel B., Hiscott P., Charteris D., Mather J., McLeod D., Boulton M. Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. BrJ Ophthalmol 1994; 78: 714-718.
38. Tuck R. R., Schmelzer J. D., Low P. A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984; 107: 935-950.
39. Omawari N., Dewhurst M., Vo P. A., Mahmood S., Stevens E., Tomlinson D. R. Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil. Br J Pharmacol 1996; 118: 186-190.
40. Barnett R., Scharschmidt L., Ko Y. H., Schlondorff D. Comparison of glomerular and mesangial prostaglandin synthesis and glomerular contraction in two rat models of diabetes mellitus. Diabetes 1987; 36: 1468-1475.
41. Craven P. A., Patterson M. C., De Rubertis F. R. Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 1988; 37: 429-435.
42. Linné T., Körner A., Rudberg S., Persson B., Aperia A. Renal functional effects of prostaglandin synthesis inhibition in patients with insulin-dependent diabetes mellitus of long duration without nephropathy. Horm Metab Res 1991; 23: 383-386.
43. Craven P. A., Caines M. A., DeRubertis F. R. Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes. Metabolism 1987; 36: 95-103.
44. Pomerantz K. B., Summers B., Hajjar D. P. Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells. Evidence for reduced posttranscriptional processing of cyclooxygenase I and reduced cyclooxygenase II gene expression. Biochemistry 1993; 32: 13624-13635.
45. Negrete H., Studer R. K, Craven P. A., DeRubertis F. R. Role for transforming growth factor beta in thromboxane-induced increases in mesangial cell fibronectin synthesis. Diabetes 1995; 44: 335-339.
46. Sharma K., Ziyadeh F. N. Hyperglycaemia and diabetic kidney disease. The case for transforming growth factor-ß as a key mediator. Diabetes 1995; 44: 1139-1146.
47. Karasu C., Dewhurst M., Stevens E.J., Tomlinson D. R. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia 1995; 38: 129-134.